GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center
GXO advances its growth strategy to serve leading global brands across sectors in Germany 70,000 automated square meter site with […]
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in […]
Healthcare Realty Trust Announces Strategic Joint Venture With KKR
Contributes seed portfolio valued at $383 million to the JV, resulting in proceeds of approximately $300 million Additional KKR capital […]
Meritage Homes Announces Offering of Convertible Senior Notes
SCOTTSDALE, Ariz., May 06, 2024 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder […]
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink
UrbanLink’s firm purchase order of 20 Lilium Jets, with an option for 20 more, includes scheduled pre-delivery payments. The agreement […]
Freshpet, Inc. Reports First Quarter 2024 Financial Results
Company Updates 2024 Outlook; Raises Adjusted EBITDA GuidanceNet Sales Driven by Volume-Based Growth Profitability Improvement Driven by Lower Input, Quality and […]
Oculis to Present at Bank of America Global Healthcare Conference
ZUG, Switzerland, and BOSTON, USA, May 06, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or […]
TSX News -
K92 Mining Announces Latest Drilling Results Extending Multiple High-Grade Zones and New Dilatant Zone Discovered
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) […]
TSX News -
Hut 8 Operations Update for April 2024
Miami, May 06, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, […]
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based […]
